Commentary
Published in:
Volume 1 / Year 2012 / Issue 3-4
Volume 1 / Year 2012 / Issue 3-4
Statin generics: no differences in efficacy after switching
Author(s): Christoph Baumgärtel, MD, MSc
Page: 116-7
Page: 116-7
Abstract: A study presented at the 2010 Congress of the European Society of Cardiology, had created a considerable stir. Its abstract allegedly showed that the originator drug Lipitor was more… Read More »
Pharmacovigilance of biosimilars: challenges and possible solutions
Page: 118-9
Author byline as per print journal: Thijs J Giezen, PharmD, PhD; Sabine MJM Straus, MD, PhD Abstract: Post-marketing surveillance is essential to detect, assess and prevent adverse reactions of chemically synthesized small… Read More »